Week 1 Flashcards
Benign Tumor
made up of non-invasive OR metastatic cells, but have lost many growth factors and specialized function of normal cells.
They are immortal
Mutational signatures
because cancers harbor many somatic point mutations, some cancers have mutational signatures consistent with a certain carcinogenic agent.
ie. UV light and melanoma and tobacco and lung cancer
Cytogenetic Analysis
used to study cancer to detect major genetic abnormalities in cancer cells and are used in clinical diagnosis
can detect: translocation and gene deletions, Loss of Heterozygosity, anueploidy.
Anueploidy and prognosis
poor prognosis
Autosomal Dominant Cancers
Familial Adenomatous Polyposis
Familial Retinoblastoma
Breast and Ovarian Cancer
Wilms Tumor
Autosomal Recessive Cancers
Xeroderma Pigmentosa
Ataxia Telangiectasia
Blooms Syndrom
Fanconi’s Congenital aplastic anmeia
Retinoblastoma Gene/protein
Tumor Suppressor
Ch 13a14 mutation
deletion, partial deletion, or rearrangement (due to PCR and southern blot)
Retinoblastoma Prevalence
Rare, pediatric disorder 1/20,000 infants
Autosomal Dominant
Inherited Retinoblastoma
DNA from normal tissue, or unaffected family, shows a defect in one RB gene, but one normal copy. They are Heterozygous, but they acquire homozygosity for the RB gene.
Retinoblastoma - how does Loss of heterozygosity occur
1) local events
2) somatic recombination (most common)
3) loss and duplication
4) chromosome loss
Growth in normal cells
Growth factors (ras, Jun) and EGFR activate CDK4,6; cycD1-3, CDK2, and CycE.
CDKS are always present, but only activated by CycD or cycE.
When CDK are activated they phosphorylated RB to inactivate it to promote cell proliferation.
RB hyperphosphorylation
Occurs in rapidly proliferating cells at S or G2
Cells begin to divide
RB hypophosphorylation
in non-proliferating cells in G0 or G1 of cell cycle.
Repressed entry into S phase
CDK phosphorylates RB
to inactivate RB to allow the cell to proceed from G1 to S
HPV E7
Binds to RB protein to inactivate it and promote cell proliferation in cervical cancer
Sporadic cases of RB
very rare 1/10^8
characterized by unilateral retinoblastoma or single tumor
Inherited cases of RB
Inherit one RB mutation and obtain second mutation
Characteristic of bilateral retinoblastoma or multiple tumors in the same eye
What types of cancer does RB predispose you to?
1) small cell lung tumors
2) breast cancer
p107 and p130
homologs to RB in human cells. They are not located in the retina, but the are located in the pituitary, so they provide protective role in tumor development in pituitary
APC
tumor supressor gene in Familial Adenomatous Polyposis
FAP
1/10,000
Autosomal Dominant disorder
but increased chance of LOH (90% will develop colon cancer by 50)
adenomatous polyps
characteristic of FAP
develop during the first 20 years of life, but become malignant by LOH
APC Gene
mapped on Ch 5q
encodes a cytoplasmic protein that regulates the localization of Beta-Catenin
Beta-Catenin
is normally sequestered to plasma membrane by Ecadherin
when WNT binds to Frizzled, it is released by membrane and can go to the nucleus to act like a transcription factor
APC Protein
cases the degradation of free beta-Catenin in cytoplasm
Mutated APC
Beta-Catenin cannot be degraded in the cytoplasm, so it moves to the nucleus t activate TCF/Lef and promotes the transcription of oncogenes like c-myc
Thus loss of APC causes over epxression of the c-myc oncogene to result in polyp formation and metastasis
BRCA1 and BRCA2 Mutations
Inherited mutations 5%
and inherited cases display LOH
Extremely penetrant
Acquired breast cancer
somatic mutations of BRCA1 or 2 have not been found in tumors, mutations in other genes may affect BRCA1 and BRCA2 function indirectly.
BRCA1 and BRCA2
are regulating checkpoint proteins that function in DNA repair
Fanconi’s Anemia D1 Gene
BRCA2 homozygous mutation that develops at 5 years of age.
They can get a bone marrow transplant and anemia is cured.
But they are at increased risk of leukemia head and neck cancer, ano-genital cancer, NOT high risk of breast cancer.
Why don’t Fanconi’s Anemia get breast cancer?
every cell in their body lacks BRCA2 gene
Women who only get breast cancer occur by loss of WT allele.
p53 mutations
mutation found in 50% of cancers
All through somatic events, rarely inherited
Most are due to missense mutations (75%)
p53 gene
tumor supressor gene
mutations in this gene causes the accumulation of mutations at a much higher rate
“guardian of the genome”
tetramer, mutant p53 binds to WT p53 to inactivate it - making it a “dominant negative”
Properties of p53
1) transcription factor to express gene that prevent replicating foreign or damaged DNA
2) apoptosis
HPV E6
inactivates p53 by leading to its degradation
HPV
normally integrates into DNA and destroys E1 repressor and promotes E6 and E7 to inhibit both RB and p53
When you put back in the E1 gene, the cells stop growing and proliferating.
If you step really hard on the tumor suppressors, it doesn’t matter how hard you press on the oncogenes!
retroviruses
RNA, membrane enclosed viruses that bud from the cell membrane and do not kill infected cell.
What genes promote the replication of a virus
Gag, Env, Pol.
replicates through intermediate proviral DNA and integrates into the host cell genome.
what gene in viruses in cancerous
v-onc has the ability to rapidly transformed appropriate cells into a malignant phenotype.
pp60c-src
a protein coded by v-src gene that is a membrane bound protein kinase that phosphorylates tyrosine residues, affecting gene expression
v-erb-B
codes for a protein that is similar in structure to EDFR.
It exhibits tyrosine specific protein kinase activity, so it is constantly sending signals inside cell to proliferate without growth factor binding.
v-ab;
similar to the c-ABL that is a protein kinase that phosphorylated tyrosine residue.
Products of oncogenes resemble
mimic hormones or growth stimulating factors either by resembling natural hormones or affect structure of the cell surface receptors.
Proto-Oncogenes
c-onc genes
cellular prototypes of v-onc in eukaryotic cells
involved in spontaneous malignancies that have nothing to do with a retrovirus.
Can produce quantitative changes (too much protein) or qualitative changes (overactive or unregulated protein)
Properties of c-onc
1) most are quite different from the v-onc genes
2) if v-onc gene originated from c-onc, these arrangements occurred during or after capture
Human Bladder Cancer Cells
have a point mutation in codon 12 or 16 of c-ras and produce protein is that is always on
Amplification of c-onc
N-myc is found amplified in neuroblastoma.
HER2/neu encodes for integral membrane protein kinase that is amplified in 20% of breast cancers
Higher levels correlate with poor prognosis
Translocations of c-onc
also an indication of poor prognosis
inappropriate and high level expression of BCR-ABL
Cancer “targeted” therapy
tumor cells can be reversed by blocking the actions of oncogenes or by added missing tumor suppressors.
1) at gene level
2) or with drugs or antibodies
Herceptin
antibody drug that inhibits the erbB2 protein and extends the life of breast cancer patients by increasing the efficacy of radiation.
Heat map
is created by hybridization of the tumor DNA to a gene chip containing human genomic DNA sequences.
Red indicates increases and blue/green indicates decreases.
Used to correlate many types of molecular data (CNV, gene expression, mutations) with relevant clinical info (tumor grade, survival, age, tumor state).
LFS
Li-Fraumeni Syndrome is a rare inherited genetic cancer disorder that greatly increases one’s risk of developing cancer during their lifetime. Sometimes people with LFS develop multiple cancers and multiple tumors often in childhood or as young adults.
70% associated with mutation in p53
LFL
Li fraumeni like syndrome
only 40% are associated with p53 mutations
clinical benefits of identifying molecular basis of LFS?
1) identification of mutation provides diagnostic certainty
2) avoid delay in diagnosis of second tumor
3) avoid radiation
4) prenatal diagnosis may be offered to families
Diagnostic criteria of LFS
proband with sarcoma diagnosed before 45 AND First degree relative with any cancer under 45 and
first or second degree relative with any cancer under 45 or a sarcoma at any age
Diagnostic criterial of LFL
A proband with any childhood cancer or sarcoma, brain tumor, or adrenal cortical tumor diagnosed before 45 years of age AND
A first- or second-degreerelative with a typical LFS cancer (sarcoma, breast cancer, brain tumor, adrenal cortical tumor, or leukemia) at any age AND
A first- or second-degreerelative with any cancer under the age of 60 years.
how is LFS or LFL detected?
Next Generation sequencing
Used to sequence only the Hot Spots of exons 5-9, or full length mRNA then check hCHk2 or PTEN
Two hit model of LFS
Hit 1: mutation on p53 in codon 273 (CGT –> CAT; arg to his)
Hit 2A: amplification of HER2 to cause breast cancer
Hit 2B: EGFR mutation in exon 21 to cause lung cancer
How do “hits” occur in cancer?
1) point mutations in oncogenes or tumor suppressors
2) amplifications and deletions
3) epigenetic silencing by methylation
4) insertion of retrovirus containing an oncogene
function of normal p53 gene
Protection from carcinogens
a transcription factor, regulation of mRNA, target of conventional chemotherapy and drugs are available to activate p53 without DNA damage.
what does p53 recognize?
stress signals from gamma irradiation, UV, genotoxic drugs, nutrition deprivation, heat/cold shock
how do genotoxic drugs activate p53?
they stimulate ATM and ART to activate Chk1 and Chk2
how is p53 regulated?
It is not in high concentration at all times, only induced when needed.
MDM2 and MDMX bind to p53 and inbits it
What does p53 cause?
cell cycle arrest; apoptosis; inhibition of angiogenesis and metastesis; DNA repair and damage prevention; inhibition of mTOR pathway; exosome mediated secretion; p53 negative feedback; cellular senescence.
p53 domains
Transcription activation domain; unstructured spacer region, tetramerization domain, NES, C-terminal DNA binding regulatory element
Mutation in LFS most often occur in DNA binding domain
how does p53 regulate growth arrest?
Activates P21, GADD45, 14-3-3omega to inhibit CDK1 (inhibits from going into S phase) and CDC2 (M phase)
how does p53 regulate apoptosis?
activates Bax and Apaf1 which activate CytoC
Cycto C and Apaf1 bind to caspase9 to lead to apoptosis
Von hippel Lindaue
AD 1:36,000 high penetrance by 65; >95% high variability of disease severity 20% due to de novo mutations
VHL gene
ch 3p25-26
Tumor Supressor Gene
Part of protein complex that targets unwanted proteins for proteosomal degradation by ubiquitination
VHL protein actions
1) regulation of hypoxia inducible TF
2) suppression of aneuploidy
3) maintenance of primary cilia/stabilization of microtubules.
VHL loss or accumulation
leads to HIF accumulation, high rate of aneuploidy, disruption of primary cilia to lead to renal cysts and renal cell carcinoma
VHL and HIF normoxic
HIF is hydroxylated by proline and asparagine hydroxylase
in presence of normal VHL, HIF is ubiquitinated by VHL protein and undergoes proteosomal degradation.
VHL and HIF hypoxic condition
mutated VHL behave like under hypoxic conditions.
HIF does not get hydroxylated and HIF is not degraded.
HIF accumulates and goes to nucleus to activate transcription factors that promote cancer growth and survival in low O2 conditions.
What types of genes get expressed with HIF?
gene involved in angiogenesis, metabolism, apoptosis to act on surrounding vasculature to make new blood vessels to provide cancer with nutrients and oxygen for survival.
What is the major cause of death in patients with VHL?
metastatic renal cell carcinomas
CNS hemangioblastomas
Hemangioblastoma
a tumor that originates from the vascular system - blood vessel rich tumors.
Cerebellar and Spinal Cord Hemangioblastomas - VHL
Occur in 60-80% of patients
Mean age of diagnosis in 30 years
located in cerebrum, brainstem, cervical spine, but NOT forebrain
Retinal Hemangioblastoma - VHL
occurs in 50% of patient
mean age at diagnosis is 25 years
if untreated lesions lead to blindness
Bilateral kidney cysts and clear cell renal carcinomas - VHL
Renal cortical tumors characterized by malignant epithelial cells occur in 75% of patients by age of 60 mean age of 39 accounts for 50% of deaths can be cystic or solid tumors tend to be bilateral and multiple
Pheochromocytomas - VHL
hormone secreting tumor that occurs in adrenal glands, but can develop tissues outside adrenal gland around arota, head and neck
25% of patients
mean age of diagnosis is 27
Type I VHL
hemangioblastoma + clear cell renal carcinoma
due to partial or total loss of VHL –> improper folding.
Molecular defect: upregulation of HIF
low risk of phenocyhromocytoma
Type 2 VHL
pheochromocytoma +/- hemangioblatoma +/- Clear cell renal carcinoma
Type 2A VHL
Hemangioblastoma + pheochromocytoma
VHL missense mutation
Molecular defect: up regulation of HIF, inability to stabalize microtubules
low risk of RCC
Type 2B VHL
Hemangioblastoma + pheochromocytoma + clear cell regnal carcinoma
VHL missense mutation
up regulation of HIF
Type 2C VHL
pheochromocytoma only VHL missence pVHL maintains ability to down-regulate HIF decreased binding to fibronectin defect in fibronectin matrix assembly.
Clear Cell Renal Carcinoma
3/4 of kidney cancers
only 4% inherited
must most are due to VHL loss or mutation
patients at risk of developing 600 tumors per kidney
Treatment of ccRC
surgical resection with either partial or radical nephrectomy.
therapy including: vascular endothelial growth factor receptor, tyrosine kinase, mTOR inhibition, immunotherapies.
Intracellular Fluid Volume
2/3
27 L
mitochondrial, vesicular, nuclear, sub-compartmental
ICF contents
14 mM Na 145 mM K (permeabe) 5 mM Cl- (permeable) 126 mM Proteins 55,000 mM water (permeable)
Extracellular Fluid Volume
interstitial vluid, lymph, plasma
1/3 or 13L
ECF contents
140 mM Na 5 mM K (+) 140 mM Cl (+) 0 Porteins 55,000 mM water (permeable)
Ion Channel structure
central pre with four peptide helices arranged symmetrically.
Reflection coefficient
how easily a permeating solute will cross the membrane
0 is as easily as water; 1 is not at all
electrochemical gradient
movement of ions due to :
1) concentration difference
2) membrane potential or electrical potential difference.
Nernst equation
used to determine when the membrane potential equilibrium will be reached
= 60/z * log (Co/Ci)
What does it mean when Vm = E
while concentrations are different, the internal charge is sufficient to keep ions from diffusion with concentration gradient.
V=IR what does these mean?
V = driving force = Vm-E
R use 1/R = Permeability or G - number of channels open
Hyponitremia
fall in external Na concentration
Ek stays the same
moves the ENa towards zero.
causes Vm to hyperpolarize slightly.
Hyperkalemia
rise in external potassium
Ek gets much ore positive and we see a very large depolarization.
Sign of hyperkalemia
severe infection, weight loss, hypotrophy, water loss and loss of K.
acute hemolytic anemia
due to crush injury, electrocution.
Glucose Transport
Glucose transports in either direction
glucose is trapped in the cell because it gets phosphorylated into G6P that does’t fit into the glucose transporter.
Glucose uptake is regulated by insulin
calcium pump in heart
at rest: ventricles are filling with blood and heart pumps 1 calcium out with the inward transport of 3 Na.’
During beat: calcium pumps into the cell in exchange for 1 Na and 1 K..
Digitalis
drug that blocks the Na/K pump
allows intracellular Na to increase, reducing secondary active transport of Na/Ca
allows Ca to rise and increase cardiac contractility.
H/K transporter
Infusion of K causes acidemia
Infusing H causes hyperkalemia
Absorption of salt at BL membrane
low sodium permeability and HIgh K permeability
Absorption of salt at AP membrane
highly permeable to Na and low permeability to K
Absorption of Na across epithelium
Na leads into the cell passively across the apical membrane and down electrochemcial gradient.
Pumped out of cell by Na/K pump on BL side.
results in a positive charge, causing Cl to pass freely with electric force and drags water along.
Mechanism of cholera
Acetyl Choline from parasympathetic NS binds to receptor in epithelium and causes the release of Ca into the cytoplasm. This stimulates adenylyl cylase that uses ATP to make cyclicAMP. cAMP activates Cl- channel on apical membrane to release serous fluid. Choleral activates adenylyl cylase to cause more release of serous fluid.
Refractory periods
absolute : no stimulus, no matter how strong, can evoke an AP
relative refractory: stronger than normal may evoke AP
This id due to Na inactivation gates being close in some channels and the cell needs time to reopen all inactivation gate.
also due to time it takes to close K channels.
Hyperkalemia and action potentials
gives steady depolarization from rest.
it allows some inactivation gates to close, so when a stimuli comes along it make not lead to an AP
Adding local anesthetic to axon for action potential
local anesthetic blocks sodium channel
Depolarization spreads, but it gradually decreases and is unable to reach threshold.
Small diameter axons and action potentials
conduct at lower velocity harder to stimulate low safety factor blocked easily by anesthetic no myelin pain fibers have small diameters
Large axons and action potentials
conduct at higher velocity easy to stimulate high safety factor myelin sheath motor axons have larger diameters
Hyperkalemia and action potential
extracellular K depolarizes cell and disrupts rhythm of SA node.
normally SA node undergoes spontaneous depolarization to reach threshold to fire AP.
hyperkalemia depolarization SA node and causes arrhythmias
Calcium can bind to the fixed negative charges outside the cell surface and tricks Na channels into thinking membrane is hyperpolarization and raises the threshold of AP.
Carbohydrates on membrane proteins are important for…
1) development
2) immune response
3) binding of viruses and toxins
4) proper protein folding
Three classes of amphipathic lipids
1) phospholipids
2) spingolipids
3) cholesterol
all derived from glycerol except for spingolipids
structure of plasma membrane
negative lipids on the inside: Phosphadidylserine, phsophatidylthanolamine, phosphatdiylinostilol
positive on outside: spingomeyline, glycolipids
cholesterol is equally distributed.
structure of ion channels
Four membrane spanning domains
six alpha helices (S1-S6)
Na and Ca have four domains linked by polypeptides
K each domain in a separate peptide
S4 has positive residues (lys or arg) every 3rd position - voltage sensing
S5, S6 and P loop is the ion conducting pathway
What form the voltage sensing region of an ion channel
S4 - lys and arg every 3rd position
metabotropic receptors
A metabotropic receptor is a type of membrane receptor of eukaryotic cells that acts through a secondary messenger. It may be located at the surface of the cell or in vesicles.
G protein coupled
Ionotropic Receptor
Ionotropic receptors form an ion channel pore.
Pentameric Ligand Gated Chennel
Cys-Loop family
GABA, nACHR, Serotonin (5-HT3Rs)
heteropentamers (5 subunits)
each subunit has four transmembrane alpha helices (m1-M4) with M2 assembling around channel.
Tetrameric ligand gated channels
Ionotropic glutamate receptors
NMDA - through to be involved in associative learning
4 subunits, each with 3 alpha helices
2 of the 4 subunits bind to glutamate and the other two bind to glycine.
Chloride Channels
CLC family - establishing negative membrane potential
Dimers in which each subunit has an ion permeation pathway with gate for chloride
each pathway is independent of each other.
another gate controls the pathways simultaneously.
mutation leads to myotonia
Aquaporin Channel
tetramer
each subunit contains permeation pathway for water, no entry of ions (especially protons).
Central pore allows ion permeation.
expressed in tissues with rapid water movement.
percentage of cytopslam
54%
Mitochondria percentage
22%
Rough ER percentage
9%
percentage of Ser and Golgi
9%
percentage of nucleus
6%
Protein transmembrane domain I
single TMD and amino acid in ER lumen.
Type 2 domain of transmembrane proteins
Single TRM and amino terminal in cyto
ER ss doens’t have to be N-Terminus
positive amino acids ortient amino end to cytosol.
Type 3 domain of transmembrane proteins
similar to Type II1 proteins except positive charge residues on C terminal side of signal ancho.
N-linked glycosylation
carbohydrate complex added to asparigine in ER lumen
must be Asn - X - Ser/Thr
catalyzed by oligosacchardie
Dolichol
lipid carrier that holds sugars
how do statins work?
inhibit HMG-CoA reductase is important in dolichol sugar complex.
pH differences between golgi and ER
ER is neutral
Cis-Golig 6.7
Function of Golgi
synthesis of complex spingolipids from ceramide
post translation modification of proteins and lipids - glycosylation and sulfation
Proteolytic processing
sorting of proteins and lipids for post-golgi compartments
Hereditary spastic paraplegia
a disease that has many different mutations that cause the same disease
progressive stiffness and contraction of lower limbs
mostly due to mutations in membrane trafficking
Phagocytosis
carried out by macrophages or neutrophils
recognize foreign organisms or apoptotic cells, engulf them and deliver to lysosome.
pinocytosis
specific uptake of ligands and receptor
LDL Receptors and cholesterol degradation
cycles between plasma membrane and lysosome
clustered in membrane pits due to AP2 (adaptor protein complex 2) that binds to clathrin.
after clathrin disassembles, forms early endosome.
Fuses with late endosome, where acidic pH causes degradation of LDL into cholesterol, fatty acids, and amino acids that are transported to cytoplasm for recycle.
Caveolae
140-150 small endocytic vesicles that form without protein coats
Important in lipid rafts
Caveolin is the scaffolding protein that coordinates the protein complex in these vesicles.
HSP 70
binds to hydorphobic patches on incomplete folded proteins and prevents aggregation
HSP 60
forms large barrel shape to make isolated chamber
ATP dependent
GroES is the cap
N-glycanase
marks misfolded protein that exits the ER for utiquitation
E1
ligase that binds and activates ubiquitin (activation)
only one!
E2
ligase that is involved in conjugation
we have 50 of these